About Dr. Farrugia

Daniel J Farrugia MD PhD is an expert in Breast Surgery and Medical co-Director of the Comprehensive Breast Surgery Program at Centegra Health System.

Dr. Farrugia is the only Fellowship-trained Breast Surgeon in McHenry County. Read More: Why you should choose a Fellowship-Trained Breast Surgeon for your breast care.

In addition to his comprehensive surgical training and specialization in breast surgery, Dr. Farrugia completed a Ph.D. focusing on inherited breast cancer at Mayo Clinic in Rochester, Minnesota.

Dr. Farrugia is board-certified by the American Board of Surgery.

“I pledge to provide superior quality care that patients recommend to family and friends without hesitation, physicians categorically prefer for their patients, purchasers select for their networks, and my team is absolutely proud of. “

CLINICAL EXPERTISE

  • Hidden Scar Breast Conservation Surgery
  • Radioactive seed localization of breast tumors
  • Nipple-sparing mastectomy
  • General Surgery
  • Premenopausal breast cancer
  • High-risk breast disease
  • Inherited breast cancer

Dr. Farrugia has trained in two of the leading institutions in the world for breast cancer. He continues to present and attend the foremost international conferences for breast cancer. Therefore, he is abreast of the latest research and management guidelines for breast cancer and breast disease.

Dr. Farrugia prides himself on achieving the optimal cosmetic result in breast surgery. Whenever possible and safe, he places incisions in hidden areas such as under the fold of the breast, around the areola, or in the arm pit for an enhanced cosmetic result.

“No woman should be reminded of her breast cancer every time she wakes up in the morning and looks in the mirror.”


BREAST CANCER RESEARCH

Besides being a fellowship-trained breast surgeon and general surgeon, Dr. Farrugia completed a Ph.D. focusing on inherited breast cancer at Mayo Clinic in Minnesota. During this time, he discovered novel techniques to determine which mutations in the BRCA1 and BRCA2 breast cancer susceptibility genes cause breast cancer and which are harmless. For this work, he received an award from the United States Department of Defense that funded his research. Dr. Farrugia’s research has helped researchers around the world identify harmful mutations in these genes.

Dr. Farrugia has published in the world’s leading scientific journals including Nature and Cancer Research. Dr. Farrugia’s breast cancer research has been cited over a thousand times in the medical literature.

Dr. Farrugia has presented his research in breast cancer at several international medical conferences. In 2016, he received a MERIT Award from the Conquer Cancer Foundation of ASCO for one of his projects that developed an inexpensive technique to determine the risks of breast cancer recurrence after surgery following neoadjuvant chemotherapy.


AWARDS AND RECOGNITION

Notable awards for his work in breast cancer include:

  • Conquer Cancer Foundation Merit Award (awarded by American Society of Clinical Oncology)
  • U.S. Department of Defense Breast Cancer Research Program Fellowship Award
  • American Association for Cancer Research Travel Scholarship Award

Blog

Vaccination after Surgery

In general, there are no contraindications to receiving vaccinations before or after surgery. Streptococcus pneumoniae (Pneumococcal) vaccine Pneumococcal vaccine is recommended for patient > 65 yrs of age. It is also recommended for patients 18 yrs and older with chronic heart, lung, renal, or metabolic disease, immunosuppressed patients and asplenic patients. Revaccination with a second dose should …

After a Pain Block

Activity Follow the instructions of your Radiologist. If you had a pain block, do not drive for eight hours following your procedure. We advise resting at home the first evening after your procedure.  The local anesthetic medication may cause weakness or numbness in the area affected by the injection (e.g., arm or leg). You may …

Dr. Farrugia publishes new breast cancer research study in Nature Publishing Group journal.

This week, the journal Modern Pathology, a Nature Publishing Group journal, published Dr. Farrugia’s research that proposes a novel algorithm that can predict the effectiveness of chemotherapy to shrink breast cancer tumors prior to surgery and the risks of tumor recurrence. Presently, a molecular test that costs $4,175 (Oncotype DX) is used to predict the chance …